NCT07152132 SCTSC Versus Trabeculectomy in Medically Uncontrolled Open-Angle Glaucoma in Pseudophakic Patients
| NCT ID | NCT07152132 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Minia University |
| Condition | Glaucoma, Open Angle |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-07-20 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-07-20 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
cyclodiode versus trabeculectomy with MMC in pseudophakic patients.
Eligibility Criteria
Inclusion Criteria: * 1\. Patients above 40 years old. 2\. POAG who underwent previous uncomplicated cataract surgery with intraocular lens implantation. 3\. Pseudophakic patients with medically uncontrolled glaucoma in spite of the use of two anti-glaucoma medications or intolerance to medical therapy. 4\. Visual field defects in both the superior and inferior hemi-fields outside the central 5 degrees of fixation. 5\. Mean deviation on perimetry ranges between -6 dB and -12 dB Exclusion Criteria: * 1\. Patients with history of previous glaucoma surgery. 2. Patients who have used topical steroids within the last three months. 3. Patients with significant media opacity, such as corneal opacity, that obstructs fundoscopic examination. 4\. Patients with ocular diseases as uveitis. 5. Patients with severe ocular surface disorders as ocular cicatricial pemphigoid. 6\. Aphakic patients. 7. Ocular interventions apart from YAG posterior capsulotomy.
Contact & Investigator
Ahmed M Eid, MD
STUDY DIRECTOR
Minia University Hospital
Frequently Asked Questions
Who can join the NCT07152132 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying Glaucoma, Open Angle. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07152132 currently recruiting?
Yes, NCT07152132 is actively recruiting participants. Contact the research team at hazem.m.abdelaziz@mu.edu.eg for enrollment information.
Where is the NCT07152132 trial being conducted?
This trial is being conducted at Minya, Egypt.
Who is sponsoring the NCT07152132 clinical trial?
NCT07152132 is sponsored by Minia University. The principal investigator is Ahmed M Eid, MD at Minia University Hospital. The trial plans to enroll 50 participants.